- Home
- GLBZ vs CRIS Comparison
GLBZ vs CRIS Comparison
Compare GLBZ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBZ
- CRIS
- Stock Information
- Founded
- GLBZ 1949
- CRIS 2000
- Country
- GLBZ United States
- CRIS United States
- Employees
- GLBZ N/A
- CRIS 33
- Industry
- GLBZ Major Banks
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLBZ Finance
- CRIS Health Care
- Exchange
- GLBZ Nasdaq
- CRIS Nasdaq
- Market Cap
- GLBZ 14.1M
- CRIS 13.5M
- IPO Year
- GLBZ N/A
- CRIS 2000
- Fundamental
- Price
- GLBZ $5.16
- CRIS $1.50
- Analyst Decision
- GLBZ
- CRIS Strong Buy
- Analyst Count
- GLBZ 0
- CRIS 3
- Target Price
- GLBZ N/A
- CRIS $21.00
- AVG Volume (30 Days)
- GLBZ 8.7K
- CRIS 102.7K
- Earning Date
- GLBZ 04-29-2025
- CRIS 05-06-2025
- Dividend Yield
- GLBZ 1.87%
- CRIS N/A
- EPS Growth
- GLBZ N/A
- CRIS N/A
- EPS
- GLBZ N/A
- CRIS N/A
- Revenue
- GLBZ $11,254,000.00
- CRIS $10,908,000.00
- Revenue This Year
- GLBZ N/A
- CRIS $2.33
- Revenue Next Year
- GLBZ N/A
- CRIS $9.78
- P/E Ratio
- GLBZ N/A
- CRIS N/A
- Revenue Growth
- GLBZ N/A
- CRIS 8.83
- 52 Week Low
- GLBZ $3.37
- CRIS $1.02
- 52 Week High
- GLBZ $6.99
- CRIS $16.99
- Technical
- Relative Strength Index (RSI)
- GLBZ 51.27
- CRIS 37.70
- Support Level
- GLBZ $4.70
- CRIS $1.06
- Resistance Level
- GLBZ $5.59
- CRIS $1.30
- Average True Range (ATR)
- GLBZ 0.27
- CRIS 0.15
- MACD
- GLBZ 0.01
- CRIS 0.07
- Stochastic Oscillator
- GLBZ 46.46
- CRIS 70.59
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.